1.44
Pmv Pharmaceuticals Inc Azioni (PMVP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
12.66%
1.69
|
1.935 | 2.615 | 2.801 | 2.952 |
|
6.10%
22.88
|
21.56 | 21.89 | 20.17 | 18.22 |
Benefits Costs and Expenses |
6.15%
22.89
|
21.57 | 21.77 | 20.19 | 18.22 |
Costs And Expenses |
6.15%
22.89
|
21.57 | 21.77 | 20.19 | 18.22 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
6.10%
-22.88
|
-21.56 | -21.89 | -20.17 | -18.22 |
Net Interest Income/Expense |
12.66%
1.69
|
1.935 | 2.615 | 2.801 | 2.952 |
Interest Income/Expense After Provision For Losses |
12.66%
1.69
|
1.935 | 2.615 | 2.801 | 2.952 |
Income/Loss From Continuing Operations Before Tax |
8.01%
-21.20
|
-19.63 | -19.15 | -17.39 | -15.27 |
Income Tax Expense/Benefit |
100.23%
0.005
|
-2.197 | 0.074 | -16.17 | - |
Income/Loss From Continuing Operations After Tax |
21.64%
-21.21
|
-17.44 | -19.23 | -1.213 | -15.27 |
|
21.64%
-21.21
|
-17.44 | -19.23 | -1.213 | -15.27 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.11%
52.01
|
51.95 | 51.57 | 51.48 | 51.45 |
Diluted Average Shares |
0.11%
52.01
|
51.95 | 51.57 | 51.48 | 51.45 |
Basic Earnings Per Share |
20.59%
-0.41
|
-0.34 | -0.37 | -0.02 | -0.30 |
Diluted Earnings Per Share |
20.59%
-0.41
|
-0.34 | -0.37 | -0.02 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):